T. Rowe Price Associates, Inc. filed Amendment No. 1 to Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 8,348,412 shares of BrightSpring Health Services common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: T. Rowe Price Associates, Inc. reported beneficial ownership of 8,348,412 shares of BrightSpring Health Services common stock.
  • Percent of class: The reported stake represents 4.2% of the outstanding class of common stock.
  • Sole voting power: T. Rowe Price disclosed sole voting power over 8,189,940 shares.
  • Sole dispositive power: The filing attributes sole power to dispose of 8,348,412 shares to T. Rowe Price.
  • Shared voting and dispositive power: Both shared voting power and shared dispositive power are reported as 0.
  • Event date: The date of the event requiring this filing is stated as September 30, 2026.
  • Filer classification: T. Rowe Price Associates, Inc. is identified as an investment adviser (type "IA"), organized in Maryland.

T. Rowe Price's BrightSpring Ownership Position as of September 30, 2026

According to the filing, T. Rowe Price Associates, Inc., an investment adviser incorporated in Maryland and headquartered at 1307 Point Street, Baltimore, MD 21231, submitted Amendment No. 1 to Schedule 13G covering common stock of BrightSpring Health Services (NASDAQ:BTSG), CUSIP 10950A106. The issuer's principal executive offices are listed at 805 N. Whittington Parkway, Louisville, KY, 40222. The triggering event date is reported as September 30, 2026, and the statement was signed by Ellen York, Vice President, on November 16, 2026.

The filing discloses that T. Rowe Price beneficially owns 8,348,412 shares in aggregate, equal to 4.2% of the class, and that this ownership falls at or below the 5-percent threshold, as noted under Item 5 of the filing. Of the total shares reported, 8,189,940 are subject to sole voting power, while the remaining shares carry no voting authority attributed to the filer. The entirety of the 8,348,412 shares is held with sole dispositive power, and no shares are reported under shared voting or shared dispositive arrangements.

The certification included in the filing states that "the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." The filing further notes that T. Rowe Price "expressly denied" that the filing constitutes an admission of beneficial ownership of the referenced securities.

What Was Disclosed

T. Rowe Price Associates, Inc. filed an amended Schedule 13G reporting beneficial ownership of 8,348,412 shares, or 4.2%, of BrightSpring Health Services common stock as of September 30, 2026, with sole voting power over 8,189,940 shares and sole dispositive power over all 8,348,412 shares.